CheckMate 227: Nivolumab + ipilimumab vs chemotherapy as 1L treatment for advanced NSCLC with high tumor mutational burden Meeting Abstract


Authors: Mathias, C.; Reck, M.; Hellmann, M.; Ramalingam, S.; Brahmer, J.; O'Byrne, K.; Bhagavatheeswaran, P.; Nathan, F.; Borghaei, H.; Paz-Ares, L.
Abstract Title: CheckMate 227: Nivolumab + ipilimumab vs chemotherapy as 1L treatment for advanced NSCLC with high tumor mutational burden
Meeting Title: IASLC Latin America Conference on Lung Cancer 2018
Keywords: patient-reported outcomes; nsclc; nivolumab; tumor mutational burden
Journal Title: Journal of Thoracic Oncology
Volume: 13
Issue: 9 Suppl.
Meeting Dates: 2018 Aug 15-18
Meeting Location: Cordoba, Argentina
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2018-09-01
Start Page: S152
End Page: S153
Language: English
ACCESSION: WOS:000444519200003
PROVIDER: wos
DOI: 10.1016/j.jtho.2018.07.021
Notes: Meeting Abstract: PS2 -- Source: Wos
Altmetric Score
MSK Authors
  1. Matthew David Hellmann
    199 Hellmann